Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer

OBJECTIVE: The Immunoscore method has proved fruitful for predicting prognosis in patients with colon cancer. However, there is still room for improvement in this scoring method to achieve further advances in its clinical translation. This study aimed to develop and validate a modified Immunoscore (...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Chin J Cancer Res
Egile Nagusiak: Zhao, Ke, Wu, Xiaomei, Li, Zhenhui, Wang, Yingyi, Xu, Zeyan, Li, Yajun, Wu, Lin, Yao, Su, Huang, Yanqi, Liang, Changhong, Liu, Zaiyi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286894/
https://ncbi.nlm.nih.gov/pubmed/34321834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.09
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak